These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15648966)

  • 41. Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome.
    El-Hadidi H; Samir N; Shaker OG; Otb S
    Arch Dermatol Res; 2014 Apr; 306(3):239-45. PubMed ID: 24052155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High sensitivity C-reactive protein.
    Fritsma G
    Clin Lab Sci; 2001; 14(4):276-278; quiz 279-80. PubMed ID: 11760828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-sensitivity C-reactive protein: clinical importance.
    Bassuk SS; Rifai N; Ridker PM
    Curr Probl Cardiol; 2004 Aug; 29(8):439-93. PubMed ID: 15258556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
    Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
    Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-reactive protein, atherosclerosis and cardiovascular disease. An update.
    Camici M
    Minerva Cardioangiol; 2002 Aug; 50(4):327-31. PubMed ID: 12147963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fat mass, abdominal fat distribution, and C-reactive protein concentrations in overweight and obese men and women.
    Maki KC; Rains TM; Bell M; Reeves MS; Farmer MV; Yasunaga K
    Metab Syndr Relat Disord; 2011 Aug; 9(4):291-6. PubMed ID: 21466377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper.
    Roberts WL; ;
    Circulation; 2004 Dec; 110(25):e572-6. PubMed ID: 15611384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a Point-Of-Care Test for High-Sensitivity C-Reactive Protein with an Established Immuno-Nephelometric Method.
    Markovic S; Armbruster FP; Dschietzig TB; Koenig W
    Clin Lab; 2015; 61(10):1585-8. PubMed ID: 26642724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients.
    Davenport C; Kenny H; Ashley DT; O'Sullivan EP; Smith D; O'Gorman DJ
    Eur J Clin Invest; 2012 Nov; 42(11):1173-9. PubMed ID: 22803952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of inflammation in cardiovascular disease: how to use C-reactive protein in clinical practice.
    Zebrack JS; Anderson JL
    Prog Cardiovasc Nurs; 2002; 17(4):174-85. PubMed ID: 12417833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormonal and nutritional effects on cardiovascular risk markers in young women.
    Lawson EA; Miller KK; Mathur VA; Misra M; Meenaghan E; Herzog DB; Klibanski A
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3089-94. PubMed ID: 17519306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-reactive protein.
    Rosalki SB
    Int J Clin Pract; 2001 May; 55(4):269-70. PubMed ID: 11406913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
    Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
    Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Waist height ratio, ultrasensitive c reactive protein and metabolic syndrome in children].
    Arnaiz P; Marín A; Pino F; Barja S; Aglony M; Navarrete C; Acevedo M
    Rev Med Chil; 2010 Nov; 138(11):1378-85. PubMed ID: 21279250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seasonal and inter-day variation in serum high-sensitivity C-reactive protein in Japanese male workers: a longitudinal study.
    Itoh H; Mori I; Matsumoto Y; Maki S; Ogawa Y
    Ind Health; 2012; 50(1):60-3. PubMed ID: 22185893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
    Genest J
    Can J Cardiol; 2004 Aug; 20 Suppl B():89B-92B. PubMed ID: 15309211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of leukocyte count and hsCRP with metabolic abnormalities in subjects with normal glucose tolerance (CURES - 64).
    Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
    J Assoc Physicians India; 2009 Jan; 57():27-32. PubMed ID: 19753755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hum Hypertens; 2008 Sep; 22(9):634-40. PubMed ID: 18528412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
    Yilmaz Y; Ongen Z
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.